NCT02639078

Single Ascending Dose Study of TD-0714 in Healthy Subjects

A Phase 1, Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD-0714 in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 56 (actual)
• Sponsor: Theravance Biopharma · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

Single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TD-0714 in healthy subjects.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	TD-0714	One time dosing in capsule formulation
DRUG	Placebo Comparator	One time dosing in capsule formulation

Timeline

• Start date: 2015-11-01
• Primary completion: 2016-02-01
• Completion: 2016-02-01
• First posted: 2015-12-24
• Last updated: 2021-10-13

Locations

1 site across 1 country: United States